Cyprotex

Cyprotex’s vision is to enable and enhance the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. By combining quality data from robust in vitro methods with contemporary in silico technology, they add value, context and relevance to the absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) data supplied to their customers in the pharmaceutical or chemical industries.